Showing results (81-90 of 91) with videos related to
Sort By:
Pageof 10
Plos One|January 18, 2019
GRP78 expression in tumor and perinephric adipose tissue is not an optimal risk stratification marker for clear cell renal cell carcinomaKunyu Shen, David A Vesey, Robert J Ellis, et al.Clinical and Experimental Pharmacology & Physiology|February 28, 2019
Pharmacological inhibition of protease-activated receptor-2 reduces crescent formation in rat nephrotoxic serum nephritisYingjie Han, Lifang Tian, Frank Ma, et al.Physiological Reports|February 17, 2025
Metabolite pathway alterations identified by magnetic resonance metabolomics in a proximal tubular epithelial cell line treated with TGF-β1Tyrone L R Humphries, Soobin Lee, Aaron J Urquhart, et al.Biochemical and Biophysical Research Communications|March 21, 2016
Decreased apoptosis repressor with caspase recruitment domain confers resistance to sunitinib in renal cell carcinoma through alternate angiogenesis pathwaysGlenda C Gobe, Keng Lim Ng, David M Small, et al.Frontiers in Physiology|March 29, 2021
PAR2 Activation on Human Kidney Tubular Epithelial Cells Induces Tissue Factor Synthesis, That Enhances Blood ClottingAbishek Iyer, Tyrone L R Humphries, Evan P Owens, et al.Archives of Medical Research|April 23, 2014
Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney diseaseMegan Rossi, Katrina L Campbell, David W Johnson, et al.Nephrology (Carlton, Vic.)|July 18, 2019
Protease-activated receptor 2 does not contribute to renal inflammation or fibrosis in the obstructed kidneyFrank Y Ma, Yingjie Han, Elyce Ozols, et al.ACS Medicinal Chemistry Letters|December 21, 2016
PAR2 Modulators Derived from GB88Mei-Kwan Yau, Ligong Liu, Jacky Y Suen, et al.Cancers|August 14, 2025
Biomarkers in Renal Cell Carcinoma: A Systematic Review and Immunohistochemical Validation StudyBrett Berezowski, Robert Boothe, Billy Chaplin, et al.Cancers|May 13, 2026
Correction: Berezowski et al. Biomarkers in Renal Cell Carcinoma: A Systematic Review and Immunohistochemical Validation Study. Cancers 2025, 17, 2588Brett Berezowski, Robert Boothe, Billy Chaplin, et al.Pageof 10